Article info

other Versions

Download PDFPDF

Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events

Authors

  1. Correspondence to Stephanie Lheureux, Medical Oncology & Hematology, Princess Margaret Hospital Cancer Centre, Toronto, ON M5G 2C, Canada; Stephanie.Lheureux{at}uhn.ca
View Full Text

Citation

Madariaga A, Bowering V, Ahrari S, et al
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events

Publication history

  • Received February 3, 2020
  • Revision received February 25, 2020
  • Accepted February 27, 2020
  • First published April 9, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.